OKLAHOMA CITY, Aug. 07, 2017 -- Federman & Sherwood announces that on August 4, 2017, a class action lawsuit was filed in the United States District Court for the Middle District of Tennessee against Envision Healthcare Corporation (NYSE:EVHC). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which is March 2, 2015 through July 21, 2017.
Plaintiff seeks to recover damages on behalf of all Envision Healthcare Corporation shareholders who purchased common stock during the Class Period and are therefore a member of the Class as described above. You may move the Court no later than Tuesday, October 3, 2017 to serve as a lead plaintiff for the entire Class. However, in order to do so, you must meet certain legal requirements pursuant to the Private Securities Litigation Reform Act of 1995.
If you wish to discuss this action, obtain further information and participate in this or any other securities litigation, or should you have any questions or concerns regarding this notice or preservation of your rights, please contact:
Robin Hester FEDERMAN & SHERWOOD 10205 North Pennsylvania Avenue Oklahoma City, OK 73120 Email to: [email protected] Or, visit the firm’s website at www.federmanlaw.com


TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 



